Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Not Applicable

Not yet recruiting

• Conditions: Screening for Colon Cancer; Survey and Questionnaire

• Registration Number: NCT06696534
• Lead Sponsor: ADVANCED MARKER DISCOVERY S.L.

Brief Summary

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

* Values of experience of participants into screening programme.

* Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Detailed Description

Multicentre, international (Spain and Portugal), no-competitive, prospective, transversal and low-risk interventional study coming from average risk participants (50-69 years old) from the colorectal cancer screening programme who are eligible to undergo analysis for screening FOBT to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis.

Study Timeline

• Study First Submitted: 2024-11-12
• Study First Submitted QC: 2024-11-16
• Study First Posted: 2024-11-20
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-19
• Last Update Posted: 2025-02-20
• Study Start: 2025-03
• Primary Completion: 2025-11
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Participants ages from 50 to 69 years (both included) at the time of informed consent signed.
• Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
• Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Exclusion Criteria

• Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.
• Participants with a previous colonoscopy in consequence of a FOBT positive result.
• Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Value of questionnaires into screening programme	12 months	The percentage of number of answers from each experience and preference questions

Trial Locations

Locations (2)

UCSP Sete Rios; 🇵🇹 Lisbon, Portugal

CS Mar Báltico; 🇪🇸 Madrid, Spain